​

Kiniksa Pharmaceuticals Ownership | Who Owns Kiniksa Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Kiniksa Pharmaceuticals Ownership Summary

Kiniksa Pharmaceuticals is owned by 0.18% institutional investors, 4.15% insiders, and 95.67% retail investors. Birchview capital, lp is the largest institutional shareholder, holding 0.04% of KNSA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.60% of its assets in Kiniksa Pharmaceuticals shares.

KNSA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKiniksa Pharmaceuticals0.18%4.15%95.67%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Birchview capital, lp30.00K0.04%$560.10K
Geode capital management---
Prudential financial---
Arrowmark colorado---
National bank of canada /fi/---
Cerity partners---
Voya investment management---
Parallel advisors---
Essex investment management---
Capula management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Birchview capital, lp30.00K0.52%$560.10K
Geode capital management---
Prudential financial---
Arrowmark colorado---
National bank of canada /fi/---
Cerity partners---
Voya investment management---
Parallel advisors---
Essex investment management---
Capula management---

Top Buyers

HolderShares% AssetsChange
Birchview capital, lp30.00K0.52%-
Pnc financial services group---8.00
Riggs asset managment---30.00
Nelson, van denburg & campbell wealth management group---34.00
Nisa investment advisors---58.00

Top Sellers

HolderShares% AssetsChange
Blackrock---4.19M
Fairmount funds management---3.20M
Hhlr advisors---3.14M
Vanguard group---2.98M
Baker bros. advisors lp---2.81M

Sold Out

HolderChange
Pnc financial services group-8.00
Riggs asset managment-30.00
Nelson, van denburg & campbell wealth management group-34.00
Nisa investment advisors-58.00
Us bancorp \de\-116.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242-60.00%127,54390.97%-1987.95%1-66.67%--
Jun 30, 20245-96.88%66,788-99.83%-0.00%3-96.47%--100.00%
Mar 31, 20241606.67%38,944,11213.77%552.33%8523.19%48-14.29%
Dec 31, 20231503.45%34,231,785-1.90%481.96%69-5624.44%
Sep 30, 20231456.62%34,893,8369.74%492.40%691.47%454.65%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.16M1.60%-92.28K
Pictet Biotech965.39K1.36%965.39K
iShares Russell 2000 ETF968.27K1.34%-2.17K
Pictet-Biotech P USD956.36K1.32%-5.26K
Vanguard Small Cap Index918.92K1.27%1.80K
Pictet-Global Megatrend Sel I USD595.91K0.83%264.50K
Vanguard Institutional Extnd Mkt Idx Tr567.21K0.80%795.00
Fidelity Small Cap Growth491.51K0.68%137.52K
Fidelity Small Cap Index383.10K0.53%-10.28K
Nuveen Quant Small Cap Equity R6336.74K0.47%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 16, 2024Tessari Eben CHIEF OPERATING OFFICERSell$470.47K
Dec 09, 2024Ragosa Mark CHIEF FINANCIAL OFFICERSell$403.23K
Dec 06, 2024Ragosa Mark CHIEF FINANCIAL OFFICERSell$190.77K
Dec 03, 2024Ragosa Mark CHIEF FINANCIAL OFFICERSell$192.39K
Dec 05, 2024Ragosa Mark CHIEF FINANCIAL OFFICERSell$23.86K

Insider Transactions Trends

DateBuySell
2024 Q4-9
2024 Q3-14
2024 Q2--
2024 Q1-11
2023 Q4-5

KNSA Ownership FAQ

Who Owns Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals shareholders are primarily institutional investors at 0.18%, followed by 4.15% insiders and 95.67% retail investors. The average institutional ownership in Kiniksa Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Kiniksa Pharmaceuticals falls below.

Who owns the most shares of Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals’s largest shareholders are Birchview capital, lp (30K shares, 0.04%), Geode capital management (0 shares, 0%), and Prudential financial (0 shares, 0%). Together, they hold 0.04% of Kiniksa Pharmaceuticals’s total shares outstanding.

Does Blackrock own Kiniksa Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Kiniksa Pharmaceuticals.

Who is Kiniksa Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Birchview capital, lp is Kiniksa Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.52% of its assets in 30K Kiniksa Pharmaceuticals shares, valued at 560.1K$.

Who is the top mutual fund holder of Kiniksa Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kiniksa Pharmaceuticals shares, with 1.60% of its total shares outstanding invested in 1.16M Kiniksa Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools